التفاصيل البيبلوغرافية
العنوان: |
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS |
المؤلفون: |
Moreau, Philippe, Chari, Ajai, Oriol, Albert, Martinez-Lopez, Joaquin, Haenel, Mathias, Touzeau, Cyrille, Ailawadhi, Sikander, Besemer, Britta, de la Rubia Comos, Javier, Encinas, Cristina, Mateos, Maria-Victoria, Salwender, Hans, Rodriguez-Otero, Paula, Hulin, Cyrille, Karlin, Lionel, Sureda Balari, Anna, Bargay, Joan, Benboubker, Lotfi, Rosiñol, Laura, Tarantolo, Stefano, Terebelo, Howard, Yang, Shiyi, Wang, Jianping, Nnane, Ivo, Qi, Ming, Kosh, Michele, Delioukina, Maria, Goldschmidt, Hartmut |
المساهمون: |
Janssen Research and Development |
المصدر: |
Blood Cancer Journal ; volume 13, issue 1 ; ISSN 2044-5385 |
بيانات النشر: |
Springer Science and Business Media LLC |
سنة النشر: |
2023 |
مصطلحات موضوعية: |
Oncology, Hematology |
نوع الوثيقة: |
article in journal/newspaper |
اللغة: |
English |
DOI: |
10.1038/s41408-023-00805-x |
الإتاحة: |
https://doi.org/10.1038/s41408-023-00805-xTest https://www.nature.com/articles/s41408-023-00805-x.pdfTest https://www.nature.com/articles/s41408-023-00805-xTest |
حقوق: |
https://creativecommons.org/licenses/by/4.0Test ; https://creativecommons.org/licenses/by/4.0Test |
رقم الانضمام: |
edsbas.1F82BCDA |
قاعدة البيانات: |
BASE |